VUPTEMO - Trademark Details
Status: 700 - Registered
Serial Number
90398064
Registration Number
6618400
Word Mark
VUPTEMO
Status
700 - Registered
Status Date
2022-01-18
Filing Date
2020-12-21
Registration Number
6618400
Registration Date
2022-01-18
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-11-02
Attorney Name
Law Office Assigned Location Code
M70
Employee Name
SNAPP, TINA LOUISE
Statements
Goods and Services
Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; blood for medical purposes; cell cultures for medical purposes, namely, cells for medical or clinical use; cell cultures for medical purposes, namely, living cells for medical use; cell cultures for medical purposes, namely, stem cells for medical or veterinary use; pharmaceutical preparations for the treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza; Pharmaceutical preparations, namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; pharmaceutical preparations, namely, antibody for the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations, namely, antibody for the treatment of Hereditary Angioedema, HAE
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-03-05
Primary Code
005
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Scott D. Woldow
Address
Please log in with your Justia account to see this address.
Foreign Application Information
| Filing Date | Application Number | Country | Foreign Priority Claim In |
| 2020-07-07 | 018269674 | EU | True |
Trademark Events
| Event Date | Event Description |
| 2020-12-24 | NEW APPLICATION ENTERED IN TRAM |
| 2021-03-05 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2021-06-16 | ASSIGNED TO EXAMINER |
| 2021-06-23 | NON-FINAL ACTION WRITTEN |
| 2021-06-23 | NON-FINAL ACTION E-MAILED |
| 2021-06-23 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2021-09-20 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-09-26 | ASSIGNED TO LIE |
| 2021-09-27 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-09-27 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-09-29 | EXAMINERS AMENDMENT -WRITTEN |
| 2021-09-29 | EXAMINERS AMENDMENT E-MAILED |
| 2021-09-29 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2021-09-29 | EXAMINER'S AMENDMENT ENTERED |
| 2021-09-29 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-10-13 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-11-02 | PUBLISHED FOR OPPOSITION |
| 2021-11-02 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2022-01-18 | REGISTERED-PRINCIPAL REGISTER |
